Myriam Schluep

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients

Patrick Aebischer, Myriam Schluep, Nicole Déglon et al. · Nature Medicine · 1996 · 452 citations · Full text

Cell-based Drug Delivery, Amyotrophic Lateral Sclerosis, Medicine +6

Principal components of functional connectivity: A new approach to study dynamic brain connectivity during rest

Nora Leonardi, Jonas Richiardi, Markus Gschwind et al. · NeuroImage · 2013 · 426 citations · Full text

Brain Structure, Neurophysiology, Neuroanatomy +13

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

Jens Kühle, Christian Barro, Giulio Disanto et al. · Multiple Sclerosis Journal · 2016 · 243 citations

Acetylcholine receptors in human thymic myoid cells in situ: An immunohistological study

Myriam Schluep, Nicholas Willcox, Angela Vincent et al. · Annals of Neurology · 1987 · 229 citations